T-30 is a synthetic 39-amino acid dual agonist peptide targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and a second key metabolic receptor. This research compound incorporates a C20 fatty diacid modification for enhanced stability and demonstrates dual receptor activity. T-30 is classified as a dual receptor agonist for research applications investigating glucose homeostasis and metabolic regulation.